Skip to main content
. Author manuscript; available in PMC: 2021 Apr 29.
Published in final edited form as: Cancer Prev Res (Phila). 2020 Jun 24;13(9):783–794. doi: 10.1158/1940-6207.CAPR-19-0412

Table 1:

Cohen’s Kappa, 95% confidence interval and percent agreement for somatic mutations measured in tumor, plasma and urine.

Specimen Comparisons Patient 1 Patient 1 (Without Missing Predictions) Patient 2 Patient 2 (Without Missing Predictions)
Tissue-Plasma 0.68 (0.42–0.93); 71% 0.84 (0.62–1.06); 86% 0.18 (−0.06–0.42); 27% 0.6 (0.19–1.01); 67%
Tissue-Urine 0.61 (0.34–0.89); 88% 0.77 (0.51–1.02);79% 0.23 (−0.02–0.47); 32% 0.6 (0.19–1.01); 67%
Plasma-Urine 0.87 (0.69–1.05); 88% 0.92 (0.76–1.08); 93% 0.82 (0.63–1.01); 86% 1 (1,1); 100%